Effects of fish oil supplementation on the fatty acid profile in erythrocyte membrane and plasma phospholipids of pregnant women and their offspring: A randomised controlled trial

British Journal of Nutrition

Volumn 109, Issue 9, 2013, Pages 1647-1656

  Escolano Margarit, M Victoria ^a   Campoy, Cristina ^a   Ramírez Tortosa, M Carmen ^a   Demmelmair, Hans ^b   Miranda, M Teresa ^a   Gil, Angel ^a   Decsi, Tamás ^c   Koletzko, Berthold V ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

DHA; Erythrocyte membrane phospholipids; Folate; Long chain PUFA; Plasma phospholipids; Pregnancy

Indexed keywords

FATTY ACID; FISH OIL; PHOSPHOLIPID;

ADULT; ARTICLE; BLOOD; CHEMISTRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; MULTICENTER STUDY; NEWBORN; PREGNANCY; RANDOMIZED CONTROLLED TRIAL;

ADULT; DOUBLE-BLIND METHOD; ERYTHROCYTE MEMBRANE; FATTY ACIDS; FEMALE; FISH OILS; HUMANS; INFANT, NEWBORN; PHOSPHOLIPIDS; PREGNANCY;

EID: 84879302559     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512003716     Document Type: Article

References (34)

1. Koletzko B, Lien E, Agostoni C, et al. (2008) The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 36, 5–14.
2. Helland IB, Saugstad OD, Saarem K, et al. (2006) Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. J Matern Fetal Neonatal Med 19, 397–406.
3. Dunstan JA, Mori TA, Barden A, et al. (2004) Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. Eur J Clin Nutr 58, 429–437.
4. Bergmann RL, Haschke-Becher E, Klassen-Wigger P, et al. (2008) Supplementation with 200 mg/day docosahexaenoic acid from mid-pregnancy through lactation improves the docosahexaenoic acid status of mothers with a habitually low fish intake and of their infants. Ann Nutr Metab 52, 157 – 166.
5. Innis SM & Friesen RW (2008) Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants. Am J Clin Nutr 87, 548–557.
6. Smuts CM, Borod E, Peeples JM, et al. (2003) High-DHA eggs: feasibility as a means to enhance circulating DHA in mother and infant. Lipids 38, 407–414.
7. Sanjurjo P, Ruiz-Sanz JI, Jimeno P, et al. (2004) Supplementation with docosahexaenoic acid in the last trimester of pregnancy: maternal–fetal biochemical findings. J Perinat Med 32, 132–136.
8. Montgomery C, Speake BK, Cameron A, et al. (2003) Maternal docosahexaenoic acid supplementation and fetal accretion. Br J Nutr 90, 135–145.
9. Otto SJ, van Houwelingen AC & Hornstra G (2000) The effect of supplementation with docosahexaenoic and arachidonic acid derived from single cell oils on plasma and erythrocyte fatty acids of pregnant women in the second trimester. Prostaglandins Leukot Essent Fatty Acids 63, 323–328.
10. Baylin A & Campos H (2006) The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol 17, 22–27.
11. Sun Q, Ma J, Campos H, et al. (2007) Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr 86, 74–81.
12. Umhau JC, Dauphinais KM, Patel SH, et al. (2006) The relationship between folate and docosahexaenoic acid in men. Eur J Clin Nutr 60, 352–357.
13. Sugiyama K, Kumazawa A, Zhou H, et al. (1998) Dietary methionine level affects linoleic acid metabolism through phosphatidylethanolamine N-methylation in rats. Lipids 33, 235–242.
14. Pita ML & Delgado MJ (2000) Folate administration increases n-3 polyunsaturated fatty acids in rat plasma and tissue lipids. Thromb Haemost 84, 420–423.
15. Krauss-Etschmann S, Shadid R, Campoy C, et al. (2007) Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am J Clin Nutr 85, 1392–1400.
16. Kolarovic L & Fournier NC (1986) A comparison of extraction methods for the isolation of phospholipids from biological sources. Anal Biochem 156, 244–250.
17. Agren JJ, Julkunen A & Penttila I (1992) Rapid separation of serum lipids for fatty acid analysis by a single aminopropyl column. J Lipid Res 33, 1871–1876.
18. Lepage G & Roy CC (1986) Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27, 114–120.
19. Helland IB, Saugstad OD, Smith L, et al. (2001) Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 108, E82.
20. Barden AE, Dunstan JA, Beilin LJ, et al. (2006) n-3 Fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clin Sci (Lond) 111, 289–294.
21. Matorras R, Perteagudo L, Sanjurjo P, et al. (1999) Intake of long chain w3 polyunsaturated fatty acids during pregnancy and the influence of levels in the mother on newborn levels. Eur J Obstet Gynecol Reprod Biol 83, 179–184.
22. Vlaardingerbroek H & Hornstra G (2004) Essential fatty acids in erythrocyte phospholipids during pregnancy and at delivery in mothers and their neonates: comparison with plasma phospholipids. Prostaglandins Leukot Essent Fatty Acids 71, 363–374.
23. Franke C, Verwied-Jorky S, Campoy C, et al. (2008) Dietary intake of natural sources of docosahexaenoic acid and folate in pregnant women of three European cohorts. Ann Nutr Metab 53, 167–174.
24. Fekete K, Marosvolgyi T, Jakobik V, et al. (2009) Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr 89, 2070S–2084S.
25. Katan MB, Deslypere JP, van Birgelen AP, et al. (1997) Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 38, 2012–2022.
26. Cao J, Schwichtenberg KA, Hanson NQ, et al. (2006) Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 52, 2265–2272.
27. Arterburn LM, Hall EB & Oken H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83, Suppl. 6, 1467S–1476S.
28. Geppert J, Kraft V, Demmelmair H, et al. (2005) Docosahexaenoic acid supplementation in vegetarians effectively increases omega-3 index: a randomized trial. Lipids 40, 807–814.
29. Courville AB, Keplinger MR, Judge MP, et al. (2009) Plasma or red blood cell phospholipids can be used to assess docosahexaenoic acid status in women during pregnancy. Nutr Res 29, 151–155.
30. Vaysse J, Dureuil M, Pilardeau P, et al. (1986) Plasma and erythrocyte lipid composition in normal pregnancy. Biol Res Pregnancy Perinatol 7, 89–92.
31. Ruyle M, Connor WE, Anderson GJ, et al. (1990) Placental transfer of essential fatty acids in humans: venous-arterial difference for docosahexaenoic acid in fetal umbilical erythrocytes. Proc Natl Acad Sci U S A 87, 7902–7906.
32. Herrera E (2002) Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development – a review. Placenta 23, S9–19.
33. Legras B, Durou MR, Ruelland A, et al. (1995) Serum lipid, apolipoprotein and lipoparticle levels in the human fetus. Prenat Diagn 15, 225–228.
34. Nagasaka H, Chiba H, Kikuta H, et al. (2002) Unique character and metabolism of high density lipoprotein (HDL) in fetus. Atherosclerosis 161, 215–223.